Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9


T lymphocyte-derived TNF and IFN-γ repress HFE expression in cancer cells.

Reuben A, Godin-Ethier J, Santos MM, Lapointe R.

Mol Immunol. 2015 Jun;65(2):259-66. doi: 10.1016/j.molimm.2015.01.029. Epub 2015 Feb 18.


Characterisation of an in vivo Pig-a gene mutation assay for use in regulatory toxicology studies.

Godin-Ethier J, Leroux F, Wang N, Thébaud S, Merah F, Nelson A.

Mutagenesis. 2015 May;30(3):359-63. doi: 10.1093/mutage/gev005. Epub 2015 Feb 13.


Fludarabine downregulates indoleamine 2,3-dioxygenase in tumors via a proteasome-mediated degradation mechanism.

Hanafi LA, Gauchat D, Godin-Ethier J, Possamaï D, Duvignaud JB, Leclerc D, Grandvaux N, Lapointe R.

PLoS One. 2014 Jun 9;9(6):e99211. doi: 10.1371/journal.pone.0099211. eCollection 2014.


Indoleamine 2,3-dioxygenase expression in human cancers: clinical and immunologic perspectives.

Godin-Ethier J, Hanafi LA, Piccirillo CA, Lapointe R.

Clin Cancer Res. 2011 Nov 15;17(22):6985-91. doi: 10.1158/1078-0432.CCR-11-1331. Epub 2011 Nov 8. Review.


IDO expression by human B lymphocytes in response to T lymphocyte stimuli and TLR engagement is biologically inactive.

Godin-Ethier J, Hanafi LA, Duvignaud JB, Leclerc D, Lapointe R.

Mol Immunol. 2011 Oct;49(1-2):253-9. doi: 10.1016/j.molimm.2011.08.017. Epub 2011 Sep 19.


Phenotypic characterization and functional analysis of human tumor immune infiltration after mechanical and enzymatic disaggregation.

Grange C, Létourneau J, Forget MA, Godin-Ethier J, Martin J, Liberman M, Latour M, Widmer H, Lattouf JB, Piccirillo CA, Cailhier JF, Lapointe R.

J Immunol Methods. 2011 Sep 30;372(1-2):119-26. doi: 10.1016/j.jim.2011.07.002. Epub 2011 Jul 18.


Androgen-regulated expression of arginase 1, arginase 2 and interleukin-8 in human prostate cancer.

Gannon PO, Godin-Ethier J, Hassler M, Delvoye N, Aversa M, Poisson AO, Péant B, Alam Fahmy M, Saad F, Lapointe R, Mes-Masson AM.

PLoS One. 2010 Aug 11;5(8):e12107. doi: 10.1371/journal.pone.0012107.


Human activated T lymphocytes modulate IDO expression in tumors through Th1/Th2 balance.

Godin-Ethier J, Pelletier S, Hanafi LA, Gannon PO, Forget MA, Routy JP, Boulassel MR, Krzemien U, Tanguay S, Lattouf JB, Arbour N, Lapointe R.

J Immunol. 2009 Dec 15;183(12):7752-60. doi: 10.4049/jimmunol.0901004.


The Wnt pathway regulator DKK1 is preferentially expressed in hormone-resistant breast tumours and in some common cancer types.

Forget MA, Turcotte S, Beauseigle D, Godin-Ethier J, Pelletier S, Martin J, Tanguay S, Lapointe R.

Br J Cancer. 2007 Feb 26;96(4):646-53. Epub 2007 Jan 23.

Supplemental Content

Loading ...
Support Center